Suppr超能文献

利妥昔单抗成功治疗儿童难治性慢性大疱性疾病

Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab.

作者信息

Mitra Debdeep, Bhatnagar Anuj, Singh Gautam K, Sandhu Sunmeet

机构信息

Department of Dermatology, Command Hospital Air Force, Bangalore, Karnataka, India.

Department of Dermatology, Base Hospital Delhi Cantt, New Delhi, India.

出版信息

Indian Dermatol Online J. 2022 Mar 3;13(2):248-251. doi: 10.4103/idoj.idoj_223_21. eCollection 2022 Mar-Apr.

Abstract

Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not responding to conventional therapy. He had earlier developed a drug reaction to dapsone which is considered the drug of choice for this condition. We report successful management of this case with injection rituximab which is a chimeric monoclonal antibody against CD20, which is primarily found on the surface of B cells.

摘要

儿童慢性大疱性疾病是一种罕见的表皮下大疱性疾病,其特征是在直接免疫荧光检查时可见沿基底膜带的线性IgA沉积。我们报告一例2岁男童病例,该患儿全身反复出现多发性大疱疹,对传统治疗无反应。他曾对氨苯砜发生药物反应,而氨苯砜被认为是治疗这种疾病的首选药物。我们报告了用注射用利妥昔单抗成功治疗该病例,利妥昔单抗是一种针对CD20的嵌合单克隆抗体,CD20主要存在于B细胞表面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/8917490/c2b55dec7c8d/IDOJ-13-248-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验